Cargando…

HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis

INTRODUCTION: HIV is considered one of the most important chronic transmitted diseases worldwide. The Joint United Nations Program on HIV/AIDS in 2020 proposed the strategy “95–95–95” which goals to achieve a 95% of cases identified, receives ART, and will have achieved suppression of the virus. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Quirola-Amores, Paulina, Espinosa, Pablo, Oleas, Sebastian, Hernandez, Isabel, Henriquez, Aquiles R., Teran, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247332/
https://www.ncbi.nlm.nih.gov/pubmed/35784197
http://dx.doi.org/10.3389/fpubh.2022.884313
_version_ 1784739141882216448
author Quirola-Amores, Paulina
Espinosa, Pablo
Oleas, Sebastian
Hernandez, Isabel
Henriquez, Aquiles R.
Teran, Enrique
author_facet Quirola-Amores, Paulina
Espinosa, Pablo
Oleas, Sebastian
Hernandez, Isabel
Henriquez, Aquiles R.
Teran, Enrique
author_sort Quirola-Amores, Paulina
collection PubMed
description INTRODUCTION: HIV is considered one of the most important chronic transmitted diseases worldwide. The Joint United Nations Program on HIV/AIDS in 2020 proposed the strategy “95–95–95” which goals to achieve a 95% of cases identified, receives ART, and will have achieved suppression of the virus. In Ecuador by 2020, according to the Ministry of Public Health, 45,056 persons are living with HIV, principally men between 15 and 49 years, and a mortality rate of 4.8/100,000 habitats. This study aims to determine the cost–utility of applying an early screening to a sexually active population vs. only a high-risk population and if the use of PrEP is justified depending on different contexts. METHODS: For the cost–utility evaluation, it was compared: (a) HIV screening performed only in the high-risk population vs. HIV screening in all population sexually active; and (b) the use of ART only for HIV treatment vs. ART as a treatment in diagnosed cases and the use of PrEP (only at a high-risk population of acquiring HIV). Calculation and weight of DALYs for HIV/SIDA were obtained through WHO guidelines. To generate the Markov model for HIV/AIDS, subjects were classified as symptomatic or asymptomatic, as well as the HIV deaths. RESULTS: Cost–benefit analysis (CUA) showed that ICER for early diagnosis had a negative value which means a saving if the strategy will be implemented as a regular test (–$591, –$4,360) and −108 and −934 DALYs, in the case of ART and PrEP, ICER the $30,541–$59,410, which resulted in more than the GDP's threshold and health years between 2,511 and 10,635 in the general population. With a reduction of 70% in the assigned budget for the early diagnosis, Ecuadorian people could lose between 4 and 6 DALYs, while if the budget reduces more than 50% to ART, it will generate a loss of 10–12 years of healthy life. CONCLUSION: CUA demonstrates that an early diagnosis in a sexually active population is cost-beneficial. This, combined with ART or PrEP, is ideal to add years of healthy life.
format Online
Article
Text
id pubmed-9247332
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92473322022-07-02 HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis Quirola-Amores, Paulina Espinosa, Pablo Oleas, Sebastian Hernandez, Isabel Henriquez, Aquiles R. Teran, Enrique Front Public Health Public Health INTRODUCTION: HIV is considered one of the most important chronic transmitted diseases worldwide. The Joint United Nations Program on HIV/AIDS in 2020 proposed the strategy “95–95–95” which goals to achieve a 95% of cases identified, receives ART, and will have achieved suppression of the virus. In Ecuador by 2020, according to the Ministry of Public Health, 45,056 persons are living with HIV, principally men between 15 and 49 years, and a mortality rate of 4.8/100,000 habitats. This study aims to determine the cost–utility of applying an early screening to a sexually active population vs. only a high-risk population and if the use of PrEP is justified depending on different contexts. METHODS: For the cost–utility evaluation, it was compared: (a) HIV screening performed only in the high-risk population vs. HIV screening in all population sexually active; and (b) the use of ART only for HIV treatment vs. ART as a treatment in diagnosed cases and the use of PrEP (only at a high-risk population of acquiring HIV). Calculation and weight of DALYs for HIV/SIDA were obtained through WHO guidelines. To generate the Markov model for HIV/AIDS, subjects were classified as symptomatic or asymptomatic, as well as the HIV deaths. RESULTS: Cost–benefit analysis (CUA) showed that ICER for early diagnosis had a negative value which means a saving if the strategy will be implemented as a regular test (–$591, –$4,360) and −108 and −934 DALYs, in the case of ART and PrEP, ICER the $30,541–$59,410, which resulted in more than the GDP's threshold and health years between 2,511 and 10,635 in the general population. With a reduction of 70% in the assigned budget for the early diagnosis, Ecuadorian people could lose between 4 and 6 DALYs, while if the budget reduces more than 50% to ART, it will generate a loss of 10–12 years of healthy life. CONCLUSION: CUA demonstrates that an early diagnosis in a sexually active population is cost-beneficial. This, combined with ART or PrEP, is ideal to add years of healthy life. Frontiers Media S.A. 2022-06-17 /pmc/articles/PMC9247332/ /pubmed/35784197 http://dx.doi.org/10.3389/fpubh.2022.884313 Text en Copyright © 2022 Quirola-Amores, Espinosa, Oleas, Hernandez, Henriquez and Teran. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Quirola-Amores, Paulina
Espinosa, Pablo
Oleas, Sebastian
Hernandez, Isabel
Henriquez, Aquiles R.
Teran, Enrique
HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
title HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
title_full HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
title_fullStr HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
title_full_unstemmed HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
title_short HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
title_sort hiv rapid testing in the general population and the usefulness of prep in ecuador: a cost–utility analysis
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247332/
https://www.ncbi.nlm.nih.gov/pubmed/35784197
http://dx.doi.org/10.3389/fpubh.2022.884313
work_keys_str_mv AT quirolaamorespaulina hivrapidtestinginthegeneralpopulationandtheusefulnessofprepinecuadoracostutilityanalysis
AT espinosapablo hivrapidtestinginthegeneralpopulationandtheusefulnessofprepinecuadoracostutilityanalysis
AT oleassebastian hivrapidtestinginthegeneralpopulationandtheusefulnessofprepinecuadoracostutilityanalysis
AT hernandezisabel hivrapidtestinginthegeneralpopulationandtheusefulnessofprepinecuadoracostutilityanalysis
AT henriquezaquilesr hivrapidtestinginthegeneralpopulationandtheusefulnessofprepinecuadoracostutilityanalysis
AT teranenrique hivrapidtestinginthegeneralpopulationandtheusefulnessofprepinecuadoracostutilityanalysis